Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

The tumor suppressor CYLD regulates the p53 DNA damage response

dc.contributor.authorFernández-Majada, Vanesa
dc.contributor.authorWelz, Patrick-Simon
dc.contributor.authorErmolaeva, Maria
dc.contributor.authorSchell, Michael
dc.contributor.authorAdam, Alexander
dc.contributor.authorDietlein, Felix
dc.contributor.authorKomander, David
dc.contributor.authorBüttner, Reinhard
dc.contributor.authorThomas, Roman K.
dc.contributor.authorSchumacher, Björn
dc.contributor.authorPasparakis, Manolis
dc.date.accessioned2022-11-09T17:37:07Z
dc.date.available2022-11-09T17:37:07Z
dc.date.issued2016
dc.date.updated2022-11-09T17:37:07Z
dc.description.abstractThe tumour suppressor CYLD is a deubiquitinase previously shown to inhibit NF-κB, MAP kinase and Wnt signalling. However, the tumour suppressing mechanisms of CYLD remain poorly understood. Here we show that loss of CYLD catalytic activity causes impaired DNA damage-induced p53 stabilization and activation in epithelial cells and sensitizes mice to chemical carcinogen-induced intestinal and skin tumorigenesis. Mechanistically, CYLD interacts with and deubiquitinates p53 facilitating its stabilization in response to genotoxic stress. Ubiquitin chain-restriction analysis provides evidence that CYLD removes K48 ubiquitin chains from p53 indirectly by cleaving K63 linkages, suggesting that p53 is decorated with complex K48/K63 chains. Moreover, CYLD deficiency also diminishes CEP-1/p53-dependent DNA damage-induced germ cell apoptosis in the nematode Caenorhabditis elegans. Collectively, our results identify CYLD as a deubiquitinase facilitating DNA damage-induced p53 activation and suggest that regulation of p53 responses to genotoxic stress contributes to the tumour suppressor function of CYLD.
dc.format.extent14 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec700997
dc.identifier.issn2041-1723
dc.identifier.pmid27561390
dc.identifier.urihttps://hdl.handle.net/2445/190635
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/ncomms12508
dc.relation.ispartofNature Communications, 2016, vol. 7
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/223151/EU//INFLA-CARE
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/260383/EU//GENSTAGE
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/309756/EU//UBSPECIFIC
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/316354/EU//CODEAGE
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/316390/EU//ADDRESS
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/316964/EU//MARRIAGE
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/323040/EU//EPINFLAM
dc.relation.urihttps://doi.org/10.1038/ncomms12508
dc.rightscc-by (c) Fernández-Majada, Vanesa et al., 2016
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationApoptosi
dc.subject.classificationCarcinogènesi
dc.subject.classificationExperimentació animal
dc.subject.otherApoptosis
dc.subject.otherCarcinogenesis
dc.subject.otherAnimal experimentation
dc.titleThe tumor suppressor CYLD regulates the p53 DNA damage response
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
700997.pdf
Mida:
1.54 MB
Format:
Adobe Portable Document Format